Skip to main content

Closed

NAUT: Nautilus Biotechnolgy, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-33043.7%

ROIC-39.5%

Financially safe

Stretched

Debt / equity0.21×

Interest coverage0.0×

Current ratio10.14×

Nautilus Biotechnolgy, Inc.

NAUTNASDAQ Capital Market·USD·Closed

Nautilus Biotechnolgy, Inc.

NAUTNASDAQ·USD·Closed

$0.98

−5.15%

$0.98

−$0.05 (5.15%)

52W Range

10thpctl

Volume

1.23×avg

Mkt Cap

124.33MUSD

P/E

-2.2TTM

Div Yield

–ann

52W Range

10thpctl

Volume

1.23×avg

Market Cap

124.33MUSD

P/E Ratio

-2.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings